Skip to main content
Caplight Logo









Nymbl Science

Nymbl Science

Private
Denver, ColoradoHealthcare & Life Scienceshttps://nymblscience.com/

Last Round

Series B

Nov 14, 2022

Total Funding Raised

$18.8M

Company Overview

Nymbl Science is a digital health company that provides a mobile application designed to improve balance, prevent falls, and enhance mobility for older adults.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

digital healthfall preventionbalance trainingmedicare advantagedual-task traininggeriatric careB2B2Ctelehealthremote patient monitoringRPMhealth outcomesSaaSsilver techage-tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nymbl Science Comparables

Compare Nymbl Science with similar companies based on industry and business-model similarity.

Nymbl Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bold
85%
TechBalance
71%
Tivity Health
69%

Nymbl Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 14, 2022
Series ANov 16, 2020
SeedOct 21, 2019
AcceleratorMay 15, 2017

Key People

Founding team and executive leadership

Edward Likovich

CEO

Executive Team

Nymbl Science Investors

Notable investors and investment history

Nymbl Science investors
InvestorRounds
Cobalt VenturesSeries B, Series A
450 VenturesSeries B
Rockies Venture ClubSeed
Outcomes CollectiveSeries B
Boomtown AcceleratorsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 104% MoM.

  • Nov 14, 2022

    $12M round led by Cobalt Ventures and Outcomes Collective.

Nymbl Science Filings

Explore SEC and related filing metadata, where available.

Nymbl Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nymbl Science's valuation, stock price, and market status.

Is Nymbl Science a public or private company?

Nymbl Science is a private company.

What is the current stock price of Nymbl Science?

Nymbl Science is a private company with no public stock price. No recent secondary market data is available.

How much is Nymbl Science worth (valuation)?

Valuation information for Nymbl Science is not publicly available.

Can I buy Nymbl Science stock?

Nymbl Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nymbl Science's last funding round?

Nymbl Science's most recent funding round was Series B on November 14, 2022.

Who are the main investors in Nymbl Science?

Key investors in Nymbl Science include Cobalt Ventures.

Will Nymbl Science IPO soon?

No public IPO plans have been announced for Nymbl Science.

How can I track Nymbl Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nymbl Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range15
Year Founded2014
Last FundingNov 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?